| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | Apr 30, 2024 | Sale | $12.04 | 2,007 | 24,169 | 39,601 | Apr 30, 2024, 06:33 PM | |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | Jan 30, 2024 | Sale | $7.99 | 2,334 | 18,649 | 36,402 | Jan 30, 2024, 06:52 PM | |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | Oct 31, 2023 | Sale | $5.20 | 1,633 | 8,487 | 33,529 | Nov 01, 2023, 04:40 PM | |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | Jul 31, 2023 | Sale | $9.65 | 1,884 | 18,189 | 29,955 | Aug 01, 2023, 04:26 PM | |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | May 01, 2023 | Sale | $9.88 | 1,136 | 11,219 | 26,632 | May 02, 2023, 04:31 PM | |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | Jan 30, 2023 | Sale | $11.78 | 1,412 | 16,633 | 23,009 | Feb 01, 2023, 04:15 PM | |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | Oct 31, 2022 | Sale | $12.88 | 1,165 | 15,006 | 21,214 | Nov 01, 2022, 07:33 PM | |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | Aug 01, 2022 | Sale | $15.67 | 1,186 | 18,585 | 19,172 | Aug 02, 2022, 05:45 PM | |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | May 02, 2022 | Sale | $11.75 | 1,098 | 12,902 | 17,151 | May 03, 2022, 07:05 PM | |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | Dec 01, 2021 | Option Exercise | $7.26 | 400 | 2,904 | 14,597 | Dec 02, 2021, 05:43 PM | |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | Dec 01, 2021 | Sale | $29.13 | 400 | 11,652 | 14,197 | Dec 02, 2021, 05:43 PM | |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | Nov 01, 2021 | Option Exercise | $7.26 | 400 | 2,904 | 14,597 | Nov 02, 2021, 05:28 PM | |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | Nov 01, 2021 | Sale | $33.24 | 400 | 13,296 | 14,197 | Nov 02, 2021, 05:28 PM | |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | Oct 27, 2021 | Option Exercise | $7.26 | 400 | 2,904 | 14,597 | Oct 28, 2021, 07:23 PM | |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | Oct 27, 2021 | Sale | $35.00 | 400 | 14,000 | 14,197 | Oct 28, 2021, 07:23 PM | |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | Oct 01, 2021 | Option Exercise | $7.26 | 400 | 2,904 | 14,597 | Oct 04, 2021, 05:16 PM | |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | Oct 01, 2021 | Sale | $29.92 | 400 | 11,968 | 14,197 | Oct 04, 2021, 05:16 PM | |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | Sep 07, 2021 | Option Exercise | $7.26 | 1,600 | 11,616 | 15,797 | Sep 08, 2021, 05:08 PM | |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | Sep 07, 2021 | Sale | $35.00 | 1,600 | 56,000 | 14,197 | Sep 08, 2021, 05:08 PM | |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | Sep 01, 2021 | Sale | $32.34 | 400 | 12,936 | 14,197 | Sep 02, 2021, 04:22 PM | |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | Sep 01, 2021 | Option Exercise | $7.26 | 400 | 2,904 | 14,597 | Sep 02, 2021, 04:22 PM | |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | Aug 02, 2021 | Option Exercise | $7.26 | 400 | 2,904 | 14,204 | Aug 03, 2021, 05:39 PM | |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | Aug 02, 2021 | Sale | $31.21 | 400 | 12,484 | 13,804 | Aug 03, 2021, 05:39 PM | |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | Jul 01, 2021 | Option Exercise | $7.26 | 400 | 2,904 | 14,204 | Jul 02, 2021, 04:03 PM | |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | Jul 01, 2021 | Sale | $26.76 | 400 | 10,704 | 13,804 | Jul 02, 2021, 04:03 PM | |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | Mar 16, 2021 | Option Exercise | $7.26 | 800 | 5,808 | 14,604 | Mar 16, 2021, 06:50 PM | |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | Mar 16, 2021 | Sale | $45.00 | 800 | 36,000 | 13,804 | Mar 16, 2021, 06:50 PM | |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | Mar 01, 2021 | Option Exercise | $7.26 | 800 | 5,808 | 14,604 | Mar 02, 2021, 05:29 PM | |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | Mar 01, 2021 | Sale | $35.95 | 800 | 28,760 | 13,804 | Mar 02, 2021, 05:29 PM | |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | Feb 18, 2021 | Option Exercise | $7.26 | 800 | 5,808 | 12,800 | Feb 22, 2021, 04:07 PM | |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | Feb 18, 2021 | Sale | $36.27 | 800 | 29,018 | 12,200 | Feb 22, 2021, 04:07 PM | |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | Nov 30, 2020 | Option Exercise | $0.84 | 12,000 | 10,080 | 12,000 | Dec 01, 2020, 09:32 PM |
Menu